Abbott’s TriClip improves tricuspid regurgitation in pivotal trial ahead of showdown with Edwards

Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system has reduced the severity of tricuspid regurgitation in a pivotal clinical trial.
The study, results from which were published in The New England Journal of Medicine, showed that TEER beat the established medical therapy on the primary composite endpoint, primarily because of its effect on a measure of quality of life.